Dashboard
Manage Tickers

MYGNMYRIAD GENETICS INC


$ 28.47 $ -0.13 (-0.45 %)    

Wednesday, 18-Sep-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.49 $ -2.05 (-0.43 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 562.20 $ -1.67 (-0.3 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 235.53 $ -1.83 (-0.77 %)
$ na
$ 28.67
$ 28.43 x 100
-- x --
$ 28.34 - $ 29.23
$ 13.82 - $ 29.30
790,493
na
2.59B
$ 1.47
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

g-iii-apparel-posts-upbeat-results-joins-nio-yext-shoe-carnival-and-other-big-stocks-moving-higher-on-thursday
G-III Apparel Posts Upbeat Results, Joins ...
09/05/2024 17:44:24

myriad-genetics-said-due-to-significant-disparities-between-genesight-group-and-control-group-myriad-concluded-that-the-control-group-was-not-viable-leading-to-the-discontinuation-of-the-second-part-of-the-study
Myriad Genetics Said Due To Significant Di...
09/04/2024 10:20:37

-8-K

wells-fargo-initiates-coverage-on-myriad-genetics-with-overweight-rating-announces-price-target-of-35
Wells Fargo Initiates Coverage On Myriad G...
08/27/2024 22:12:37

Wells Fargo analyst Brandon Couillard initiates coverage on Myriad Genetics (NASDAQ:MYGN) with a Overweight rating and annou...

scotiabank-maintains-sector-outperform-on-myriad-genetics-raises-price-target-to-34
Scotiabank Maintains Sector Outperform on ...
08/13/2024 15:28:07

Scotiabank analyst Sung Ji Nam maintains Myriad Genetics (NASDAQ:MYGN) with a Sector Outperform and raises the price target ...

myriad-genetics-stock-a-deep-dive-into-analyst-perspectives-5-ratings
Myriad Genetics Stock: A Deep Dive Into An...
08/13/2024 13:01:04

piper-sandler-maintains-neutral-on-myriad-genetics-raises-price-target-to-30
Piper Sandler Maintains Neutral on Myriad ...
08/13/2024 11:19:11

Piper Sandler analyst John Peterson maintains Myriad Genetics (NASDAQ:MYGN) with a Neutral and raises the price target from ...

td-cowen-maintains-hold-on-myriad-genetics-raises-price-target-to-30
TD Cowen Maintains Hold on Myriad Genetics...
08/07/2024 21:18:47

TD Cowen analyst Dan Brennan maintains Myriad Genetics (NASDAQ:MYGN) with a Hold and raises the price target from $28 to $30.

jp-morgan-maintains-underweight-on-myriad-genetics-raises-price-target-to-20
JP Morgan Maintains Underweight on Myriad ...
08/07/2024 17:43:06

JP Morgan analyst Rachel Vatnsdal maintains Myriad Genetics (NASDAQ:MYGN) with a Underweight and raises the price target fro...

myriad-genetics-sees-fy24-gross-revenue-835m-845m-vs-831m-estimate
Myriad Genetics Sees FY24 Gross Revenue $8...
08/06/2024 21:20:16

myriad-genetics-q2-2024-adj-eps-005-beats-001-estimate-sales-211500m-beat-204954m-estimate
Myriad Genetics Q2 2024 Adj. EPS $0.05 Bea...
08/06/2024 20:54:37

Myriad Genetics (NASDAQ:MYGN) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.0...

Core News & Articles
Myriad Genetics And Personalis Announce Cr...
07/11/2024 13:01:05

myriad-genetics-secures-second-patent-to-enhance-tumor-informed-high-definition-molecular-residual-disease-mrd-assay
Myriad Genetics Secures Second Patent To E...
07/09/2024 13:04:21

key-takeaways-from-myriad-genetics-analyst-ratings
Key Takeaways From Myriad Genetics Analyst...
06/27/2024 14:00:36

scotiabank-initiates-coverage-on-myriad-genetics-with-sector-outperform-rating-announces-price-target-of-29
Scotiabank Initiates Coverage On Myriad Ge...
06/27/2024 12:59:25

Scotiabank analyst Sung Ji Nam initiates coverage on Myriad Genetics (NASDAQ:MYGN) with a Sector Outperform rating and annou...

myriad-genetics-collaborates-with-gsk-to-improve-access-on-homologous-recombination-deficiency-testing-in-9-countries
Myriad Genetics Collaborates With GSK To I...
06/11/2024 12:06:59

myriad-genetics-launches-new-universal-plus-panel-for-its-foresight-carrier-screen
Myriad Genetics Launches New Universal Plu...
06/04/2024 13:01:10

Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced the addition of a new ...

myriad-genetics-patient-outcomes-study-validating-riskscore-as-clinical-breast-cancer-risk-assessment-tool-published-in-medical-genetics-and-genomics
Myriad Genetics Patient-Outcomes Study Val...
06/03/2024 20:13:52

jefferies-assumes-myriad-genetics-at-underperform-lowers-price-target-of-20
Jefferies Assumes Myriad Genetics at Under...
06/03/2024 13:11:27

Jefferies analyst Tycho Peterson assumes Myriad Genetics (NASDAQ:MYGN) with a Underperform rating and lowers Price Target of...

Core News & Articles
QIAGEN And Myriad Genetics To Develop Glob...
05/30/2024 20:30:33

myriad-genetics-study-published-in-jco-precision-oncology-shows-cos-prolaris-test-can-predict-benefit-of-hormone-therapy-treatment-in-men-with-localized-prostate-cancer
Myriad Genetics Study Published In JCO Pre...
05/16/2024 20:30:28

Myriad's Prolaris Test is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiat...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION